61.44
Metsera Inc (MTSR) 最新ニュース
Pfizer Sues Novo, Metsera for Second Time in Brewing Deal War - Bloomberg.com
Pfizer Files Antitrust Suit to Block Novo Nordisk Acquisition of Metsera - The Wall Street Journal
Pfizer (PFE) Files Lawsuit Against Novo Nordisk Over Metsera Bid - GuruFocus
Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle - Benzinga
Pfizer files second lawsuit against Novo Nordisk, Metsera in battle over obesity startup - statnews.com
Pfizer sues Novo Nordisk and Metsera once againbid considered to restrict competition - MarketScreener
Pfizer files second lawsuit against Metsera, Novo Nordisk - The Mighty 790 KFGO
Pfizer files second lawsuit in fight over Metsera - Axios
Pfizer files second lawsuit against Metsera, Novo Nordisk By Reuters - Investing.com
Pfizer files fresh US lawsuit against Novo Nordisk bid for Metsera - MLex
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk - The Globe and Mail
Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war - Pharmaceutical Technology
Pfizer Gains Early FTC Clearance for Metsera Acquisition - Zacks Investment Research
Pfizer Sues To Block Metsera’s Move Toward Novo Nordisk Deal - Finimize
Metsera, Inc. Responds to Pfizer Litigation - TradingView
Novo Nordisk's acquisition dream may face opposition from Trump - medwatch.com
Biggest stock movers Monday: BRK.A, NIO, and more (NASDAQ:MTSR) - Seeking Alpha
Pfizer, Novo Nordisk Clash Over Metsera Acquisition - 조선일보
Pfizer sues Metsera over Novo's shock counteroffer, but obesity biotech stands firm - Fierce Biotech
Novo Nordisk Stock: Desperate Move (NYSE:NVO) - Seeking Alpha
Metsera (MTSR) Jumps 20% as Big Pharma Battle Heats Up Over Takeover - MSN
The Battle For Metsera Acquisition Heats Up As Pfizer Files A Second Lawsuit - Stocktwits
Pfizer sues Novo Nordisk and Metsera - MarketScreener
Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk - MSN
Pfizer (PFE) Sues Over Metsera Acquisition Bid - GuruFocus
Pfizer sues Metsera, Novo Nordisk to block rival bid - Seeking Alpha
How Metsera Inc. stock reacts to Fed rate cutsPortfolio Growth Summary & Community Shared Stock Ideas - newser.com
Metsera Inc. stock chart pattern explainedEntry Point & Daily Technical Forecast Reports - newser.com
Key facts: Pfizer to report Q3 earnings on Nov 4; faces legal battle over Metsera - TradingView
Why Metsera Inc. stock attracts global investorsWall Street Watch & Low Risk High Reward Ideas - newser.com
Will Metsera Inc. stock gain from lower inflationJuly 2025 Action & Fast Entry and Exit Trade Plans - newser.com
Pfizer sues to block Novo Nordisk's Metsera takeover bid - pharmaphorum
Real Madrid to Seek Damages After Antitrust Ruling Against UEFA - PYMNTS.com
Novo Nordisk submits proposal to acquire Metsera - Medical Dialogues
The week in pharma: action, reaction and insight – week to October 31 - The Pharma Letter
Why Pfizer Can Still Prevail in the Obesity Fight With Novo NordiskWSJ - The Wall Street Journal
What Fibonacci levels say about Metsera Inc. reboundAnalyst Downgrade & Entry and Exit Point Strategies - newser.com
Metsera Inc. $MTSR Shares Sold by Jennison Associates LLC - MarketBeat
Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera - MSN
10 Stocks With Easy 20-40% Gains - Insider Monkey
Is Metsera Inc. forming a bottoming baseStop Loss & Technical Pattern Based Signals - newser.com
Key facts: Pfizer gains antitrust approval for Metsera; faces lawsuits - TradingView
Pfizer sues Metsera, Novo in effort to enforce buyout deal - BioPharma Dive
Pfizer Sues Metsera to Block Novo Nordisk’s $9B “Bribe” Deal - USA Herald
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid - RNZ
Pfizer goes to court to stop Novo Nordisk bid for Metsera - The Pharma Letter
Is Metsera Inc. building a consolidation base2025 Analyst Calls & Fast Entry High Yield Stock Tips - newser.com
Novo makes a play for Metsera; This week’s other big deal; Earnings in full swing; and more - Endpoints News
Pfizer sues to block Novo Nordisk’s bid for Metsera in high-stakes pharma clash - TradingView
Pfizer Sues to Block Novo Bid for Obesity Drugmaker Metsera - MSN
Novo Nordisk Submits Revised Bid For Metsera, Enters A Bidding War With Pfizer - MSN
Pfizer Sues Metsera, Novo Nordisk Over $9B Buyout 'Bribe' - Law360
Key facts: Novo Nordisk bids $9B for Metsera; job cuts near completion - TradingView
Pfizer secures early termination, launches lawsuit over Metsera deal - Global Competition Review
Pfizer sues to stop rival bid for drugmaker Metsera by Denmark’s Novo Nordisk - CBS 42
Pfizer files lawsuit to block Novo Nordisk's bid for Metsera - Axios
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid By Reuters - Investing.com
Metsera (MTSR) Responds to Pfizer's Legal Action - GuruFocus
Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug DealWSJ - The Wall Street Journal
Pfizer Gets Nod to Proceed With Metsera Deal From US Regulators - Bloomberg.com
Pfizer Sues Novo, Metsera Over $6.5 Billion Bid - Investor's Business Daily
大文字化:
|
ボリューム (24 時間):